{"id":83,"date":"2020-03-23T15:22:55","date_gmt":"2020-03-23T09:52:55","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19\/?page_id=83"},"modified":"2020-12-24T12:40:43","modified_gmt":"2020-12-24T07:10:43","slug":"resources","status":"publish","type":"page","link":"https:\/\/nclinnovations.org\/covid19\/resources\/","title":{"rendered":"Resources &#038; Reports"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<h2 class=\"\"><strong>Information resources and records:<\/strong><\/h2>\n<p class=\"\">(Note: &nbsp;Public view documents are free to use and download under the <a href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/legalcode\" target=\"_blank\" rel=\"noopener noreferrer\">Creative Commons Attribution- Non Commercial &#8211; ShareAlike license<\/a>.&nbsp;Some resources are restricted to only Coordinators, Nerve Center Team, Advisory Group) &nbsp;<\/p>\n<p class=\"color-3-text-contrast color3-background-color\">&nbsp;<em><strong>Latest additions: 1) <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/12\/TFORD-MoleculeBriefs-31-Molnupiravir-v1.pdf\" target=\"_blank\" rel=\"noopener\">Molecule Brief 31: Molnupiravir<\/a> (Ver 8 Dec &nbsp;2020), 2) <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/12\/TFORD_CTs_Update_Dec_2020.pdf\" target=\"_blank\" rel=\"noopener\">Clinical Trials Update:&nbsp;Outcomes from Interventional Studies for Key Drugs Studied by TFORD (30 Nov 2020)<\/a><\/strong><\/em><\/p>\n<ul class=\"\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><strong>Molecule Briefs &nbsp;<\/strong>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-01-Chloroquine-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 1: Chloroquine<\/a> (Ver 30 March 2020)<\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-02-Hydroxychloroquine-v2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 2: Hydroxychloroquine<\/a> (Ver 30 March 2020; Updated 5 April 2020)<\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-03-Remdesivir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 3: Remdesivir<\/a> (Ver 30 March 2020)| &nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-03-Remdesivir-v2-June2020.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Remdesivir<\/strong><\/a><strong> (Updated June 2020)&nbsp;<\/strong><\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-04-LopinavirRitonavir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 4: Lopinavir\/Ritonavir<\/a> (Ver 30 March 2020)<\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-05-Favipiravir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 5: Favipiravir<\/a> (Ver 30 March 2020) | &nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-05-Favipiravir-v2-June2020.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Favipiravir&nbsp;<\/strong><\/a><strong> (Updated June 2020)&nbsp;<\/strong><\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-06-BaloxavirMarboxil-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 6: Baloxavir Marboxil<\/a> (Ver 30 March 2020)<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-07-Darunavir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 7: Darunavir<\/a>&nbsp;(Ver 12 April 2020)<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-08-RibavarinIFNbeta-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 8: Ribavarin + IFN-beta<\/a> &nbsp;(Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-09-Galidesivir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 9: Galidesivir<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-10-Oseltamivir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 10: Oseltamivir<\/a> (Ver 12 April &nbsp;2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-11-Umifenovir-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 11: Umifenovir<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-12-CamostatMesylate-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 12: Camostat mesylate<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-13-Ruxolitinib-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 13: Ruxolitinib<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-14-IFNbeta-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 14: IFN-beta<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-15-Tocilizumab-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 15: Tocilizumab<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-16-Ustekinumab-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 16: Ustekinumab<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-17-Nigericin-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 17: Nigericin<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-18-Teicoplanin-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"> Molecule Brief 18: Teicoplanin<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li style=\"text-align: left;\">&nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-MoleculeBriefs-19-Ivermectin-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 19: Ivermectin<\/a> (Ver 12 April 2020)&nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-20-Baricitinib-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 20: Baricitinib<\/a> (Ver 18 June 2020) &nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-21-Tofacitinib-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 21: Tofacitinib<\/a> (Ver 18 June 2020) &nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-22-Dexamethasone-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 22: Dexamethasone<\/a> (Ver 18 June 2020)&nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-23-Sarilumab-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 23: Sarilumab<\/a> (Ver 18 June 2020) &nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-24-Sepsivac-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 24: Sepsivac<\/a> (Ver 18 June 2020) &nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-25-Ulinastatin-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 25: Ulinastatin<\/a> (Ver 18 June 2020) &nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-26-Nitazoxanide-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 26: Nitazoxanide<\/a> (Ver 18 June 2020)&nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-27-Enoxaparin-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 27: Enaxoparin<\/a> (Ver 18 June 2020)&nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-28-Famotidine-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 28: Famotidine<\/a> (Ver 18 June 2020)&nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-29-ACEiARB-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 29: ACEi and ARB<\/a> (Ver 18 June 2020)&nbsp;<\/li>\n<li>&nbsp; <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-MoleculeBriefs-30-rACEprotein-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Molecule Brief 30: rhACE protein<\/a> (Ver 18 June 2020)&nbsp;<\/li>\n<li>&nbsp;<strong> <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/12\/TFORD-MoleculeBriefs-31-Molnupiravir-v1.pdf\" target=\"_blank\" rel=\"noopener\">Molecule Brief 31: Molnupiravir<\/a> (Ver 8 Dec &nbsp;2020) &nbsp;<span style=\"color: #ff0000;\">NEW!!!<\/span><\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul class=\"\" style=\"background-color: #ffffff;\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul class=\"\">\n<li><strong>Medicinal Herbs Brief&nbsp;<\/strong>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ol>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-01-Tinospora-cordifolia-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Tinospora cordifolia<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-02-Glycyrrhiza-glabra-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Glycyrrhiza glabra<\/a> (Ver 13 May 2020) &nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-03-Withania-somnifera-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Withania somnifera<\/a> (Ver 13 May 2020) &nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-04-Zingiber-officinale-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Zingiber officinale<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-05-Andrographis-paniculata-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Andrographis paniculata<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-06-Artemisia-annua-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Artemisia annua<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-07-Cissampelos-pareira-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Cissampelos pareira<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-08-Vitis-vinifera-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Vitis vinifera<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/TFORD-HerbalBriefs-09-Myrica-cerifera-v1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Myrica cerifera<\/a> (Ver 13 May 2020)&nbsp;<\/li>\n<\/ol>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul class=\"\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul class=\"\">\n<li><strong>Information trackers<\/strong>:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"http:\/\/nclinnovations.org\/covid19monitor\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Drug Monitor<\/strong>:<\/a> We are tracking the latest information on key drug candidates for COVID19 (Credits: Dr Smita Kale) <em><span style=\"color: #ff0000;\"><strong>UPDATED!<\/strong><\/span><\/em><\/li>\n<li><strong>Clinical Trials (Interventional) in India<\/strong> (Credits: Dr Kirtee Wani)&nbsp;\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><strong>Update on 4 September 2020: <a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/188Bkbb16MaRg8VGvsFH9J3QQ_-SxyGgP9nUIFIXANog\/edit?ts=5f5370af#gid=159465981\" target=\"_blank\" rel=\"noopener noreferrer\">Interventional CTs registered in India<\/a>&nbsp;<span style=\"color: #ff0000;\"><em>NEW!! NEW!!<\/em><\/span><\/strong><\/li>\n<li>Update on 29 June 2020: <a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/14CQnOETdBDwTjx_MxgkCNBT-rL2XFvTg9w0yLOyR50s\/edit#gid=0\" target=\"_blank\" rel=\"noopener noreferrer\">Interventional CTs registered in India<\/a>&nbsp;<\/li>\n<li>Update on &nbsp;9 May 2020:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1is_1OCRUPSdrGRrDpMGz1qrR7rGRgGqXT-m7zkgog6U\/edit#gid=0\" target=\"_blank\" rel=\"noopener noreferrer\">List of Clinical Trials Registered in India (only interventional)- last update 9 May 2020<\/a><\/li>\n<li><a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1is_1OCRUPSdrGRrDpMGz1qrR7rGRgGqXT-m7zkgog6U\/edit#gid=1427690307\" target=\"_blank\" rel=\"noopener noreferrer\">Summary analysis of CTs registered in India &#8211; last update 9 May 2020<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul class=\"\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs.png\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-252\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-300x174.png\" alt=\"\" width=\"300\" height=\"174\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-300x174.png 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-768x445.png 768w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-656x380.png 656w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-250x145.png 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-550x319.png 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-800x464.png 800w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-311x180.png 311w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-518x300.png 518w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs-863x500.png 863w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/05\/India-CTs.png 985w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/li>\n<li style=\"list-style-type: none;\">&nbsp;\n<ul>\n<li><strong>Heat maps:<\/strong> &nbsp;See how our experts rate different molecules and the journey ahead:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Heat map 1: Status of Drug Candidates and their Potential\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Update on 30 Nov 2020:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/12\/TFORD_CTs_Update_Dec_2020.pdf\" target=\"_blank\" rel=\"noopener\"><em><strong>Clinical Trials Update:&nbsp;Outcomes from Interventional Studies for Key Drugs Studied by TFORD<\/strong><\/em><\/a> &nbsp;<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/07\/TFORD-30June2020-ver10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>NEW NEW!!&nbsp;<\/strong><\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li>Update on 1 Sep 2020:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\"><a style=\"color: #000000;\" href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/09\/TFORD_Clinical_Data_Update_Final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical Trials Update:&nbsp;Outcomes from Interventional Studies for Key Drugs Studied by TFORD<\/a> <\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li>Update on 26 Apr 2020:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><em><strong>Drug Candidate Readiness and Potential<\/strong> <\/em>&nbsp;&#8212; &nbsp;Heat Map <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugCandidates.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">PDF document<\/a> | &nbsp;<a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1Oul-dYq6V3uuFqLwxGbWv1e4WXCtp7tiBuFx5DT-cVY\/edit#gid=1767203745\" target=\"_blank\" rel=\"noopener noreferrer\">Google Sheet<\/a> (26 April 2020)&nbsp;\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Summary Chart for Readiness and Potential (<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential.png\" target=\"_blank\" rel=\"noopener noreferrer\">png<\/a> | <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-HeatMap-1-DrugPotential.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">pdf<\/a>)<\/li>\n<li>Scoring scales for summary chart (<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-Scores.png\" target=\"_blank\" rel=\"noopener noreferrer\">png<\/a> |<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-HeatMap-1-DrugPotential-Scores.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">pdf<\/a>)&nbsp;<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"\" style=\"padding-left: 80px;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential.png\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-196\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-300x145.png\" alt=\"\" width=\"300\" height=\"145\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-300x145.png 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-1024x496.png 1024w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-768x372.png 768w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-784x380.png 784w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-250x121.png 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-550x266.png 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-800x388.png 800w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-372x180.png 372w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential-619x300.png 619w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-1-DrugPotential.png 1028w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<ul class=\"\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Heat map 2: <em><strong>Patent Position<\/strong><\/em>&nbsp; (Credits: Dr Vidula Walimbe &amp; Gnanlex team)\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><em><strong>Update on 17 June 2020: &nbsp;<a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1ufRaS5djRK3miZNZgufdJk0CYq5YFy6Ly4MPHyayeaQ\/edit?ts=5f4b4dbe#gid=2144890943\" target=\"_blank\" rel=\"noopener noreferrer\">Google Sheet <\/a><a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/14CQnOETdBDwTjx_MxgkCNBT-rL2XFvTg9w0yLOyR50s\/edit#gid=1427690307\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color: #ff0000;\">UPDATED!<\/span><\/a><\/strong><\/em><\/li>\n<li>Update on 26 April 2020\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Heat Map <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">PDF document<\/a> | &nbsp;<a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1v9aNCwLxymRY0ERPr80MULWbPZlQfNOArMhYQUn1Yuk\/edit#gid=0\" target=\"_blank\" rel=\"noopener noreferrer\">Google Sheet<\/a><\/li>\n<li>Summary Chart for Patent Barriers (<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1.png\" target=\"_blank\" rel=\"noopener noreferrer\">png<\/a> | <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-IP-Pt1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">pdf<\/a>)<\/li>\n<li>Summary Chart for Patent-related Need for GoI Action (<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2.png\" target=\"_blank\" rel=\"noopener noreferrer\">png<\/a> | <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-IP-Pt2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">pdf<\/a>)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"\" style=\"padding-left: 80px;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1.png\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-201\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-300x186.png\" alt=\"\" width=\"300\" height=\"186\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-300x186.png 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-613x380.png 613w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-250x155.png 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-550x341.png 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-290x180.png 290w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1-484x300.png 484w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt1.png 690w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p class=\"\" style=\"padding-left: 80px;\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2.png\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-202\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-300x166.png\" alt=\"\" width=\"300\" height=\"166\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-300x166.png 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-768x425.png 768w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-686x380.png 686w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-250x138.png 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-550x305.png 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-325x180.png 325w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2-542x300.png 542w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-2-Patents-Pt2.png 773w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<ul class=\"\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Heat map 3: <strong><em>Clinical Trials Reported<\/em> <\/strong>&#8212; &nbsp;Heat Map <a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-3-ClinicalTrials.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">PDF document<\/a> | &nbsp;<a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1lZb5x7GbfB1EMz5Oyorz-wX5_NPYwewRi9l6qhPyeg0\/edit#gid=0\" target=\"_blank\" rel=\"noopener noreferrer\">Google Sheet<\/a> (26 April 2020)&nbsp;\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Summary Chart for Clinical Trials with published results (<a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Heatmap-3-CT.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">pdf<\/a>)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"\">&nbsp;<\/p>\n<ul class=\"\" style=\"background-color: #ffffff;\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Heat map 4: <em><strong>Indian manufacturers of drug candidates<\/strong><\/em> studied by TFORD&nbsp;\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1rCA-CqsM9Rl1oZugRUfnpM-pYjQ7fZTtQbcffftZV6w\/edit?usp=sharing\" target=\"_blank\" rel=\"noopener noreferrer\">Explore in Google sheet<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs.png\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-321\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-300x218.png\" alt=\"\" width=\"300\" height=\"218\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-300x218.png 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-768x559.png 768w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-522x380.png 522w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-250x182.png 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-550x401.png 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-247x180.png 247w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-412x300.png 412w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs-687x500.png 687w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/DrugMfrs.png 780w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<ul class=\"\" style=\"background-color: #ffffff;\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Heat map 5: Selected <em><strong>medicinal herbs<\/strong><\/em>, status of CTs in India and selected major Indian manufacturers\/ suppliers\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1pipmjM7oO9RjMCtG1u09uRaXzSutgroX9CE0VgHKDiY\/edit?usp=sharing\" target=\"_blank\" rel=\"noopener noreferrer\">Explore in Google sheet<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"\"><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs.png\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-322\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-300x188.png\" alt=\"\" width=\"300\" height=\"188\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-300x188.png 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-768x481.png 768w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-606x380.png 606w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-250x157.png 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-550x345.png 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-800x502.png 800w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-287x180.png 287w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-479x300.png 479w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs-798x500.png 798w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/06\/HerbMfrs.png 855w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<ul class=\"\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Assessment and categorisation frameworks&nbsp;\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Scientific evidence and technology de-risking<\/li>\n<li><a href=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/TFORD-Framework-IP-ver05-Public.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intellectual property<\/a> (Ver 30 March 2020)<\/li>\n<li>Supply chain, manufacturing, financing<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"list-style-type: none;\">&nbsp;\n<ul>\n<li>Funding options:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/iusstf.org\/assets\/sitesfile\/image\/counselling\/announcement_1677132591.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">USISTEF<\/a>&#8212; COVID-19 Ignition Grants: 15 April &#8211; 15 May 2020<\/li>\n<li><a href=\"http:\/\/serb.gov.in\/pdfs\/what-new\/CRG_One%20Year%20April%202%202020_a.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">SERB-CRG for COVID19<\/a>: 2 -30 Apr 2020<\/li>\n<li><a href=\"http:\/\/serb.gov.in\/pdfs\/what-new\/SERB_IRHPA_COVID_2020_Call-1_30Aprilnew.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">SERB-IRHPA for COVID19<\/a>: 19 March &#8211; 30 April 2020<\/li>\n<li><a href=\"https:\/\/www.birac.nic.in\/desc_new.php?id=703\" target=\"_blank\" rel=\"noopener noreferrer\">DBT and BIRAC Funding Call<\/a> (includes Repurposing of Drugs): 5 April &#8211; 15 May 2020<\/li>\n<li><a href=\"https:\/\/www.birac.nic.in\/desc_new.php?id=216\" target=\"_blank\" rel=\"noopener noreferrer\">BIRAC- BIPP<\/a> funds trials: <a href=\"https:\/\/www.birac.nic.in\/cfp_view.php?id=72&amp;scheme_type=1\" target=\"_blank\" rel=\"noopener noreferrer\">15 Feb -30 April 2020<\/a><\/li>\n<li><a href=\"https:\/\/www.birac.nic.in\/desc_new.php?id=639\" target=\"_blank\" rel=\"noopener noreferrer\">BIRAC- ATGC (includes drugs)<\/a>: Ongoing<\/li>\n<li><a href=\"https:\/\/www.csir.res.in\/csir-nmitli\" target=\"_blank\" rel=\"noopener noreferrer\">CSIR-NMITLI &#8220;Breakthrough technology interventions against COVID19&#8221;<\/a>: Till 5 April 2020<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"list-style-type: none;\">&nbsp;\n<ul>\n<li>Useful links&nbsp;\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\" target=\"_blank\" rel=\"noopener noreferrer\">WHO site for COVID19<\/a><\/li>\n<li><a href=\"https:\/\/www.nejm.org\/coronavirus\" target=\"_blank\" rel=\"noopener noreferrer\">NEJM site for COVID19<\/a><\/li>\n<li><a href=\"https:\/\/media.nature.com\/original\/magazine-assets\/d41573-020-00016-0\/17663286\" target=\"_blank\" rel=\"noopener noreferrer\">Therapeutic Options from Nature Discovery<\/a><\/li>\n<li><a href=\"https:\/\/www.elsevier.com\/connect\/coronavirus-information-center\" target=\"_blank\" rel=\"noopener noreferrer\">Elsevier SARS-CoV-2 Information &nbsp;Center<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"\" style=\"text-align: center;\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-medium wp-image-125\" src=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-300x55.jpg\" alt=\"\" width=\"300\" height=\"55\" srcset=\"https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-300x55.jpg 300w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-768x142.jpg 768w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-250x46.jpg 250w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-550x102.jpg 550w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-800x148.jpg 800w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2-974x180.jpg 974w, https:\/\/nclinnovations.org\/covid19\/wp-content\/uploads\/2020\/04\/Tford-Covid-19-2.jpg 990w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Information resources and records: (Note: &nbsp;Public view documents are free to use and download under the Creative Commons Attribution- Non Commercial &#8211; ShareAlike license.&nbsp;Some resources are restricted to only Coordinators, Nerve Center Team, Advisory Group) &nbsp; &nbsp;Latest additions: 1) Molecule Brief 31: Molnupiravir (Ver 8 Dec &nbsp;2020), 2) Clinical Trials Update:&nbsp;Outcomes from Interventional Studies for &hellip; <a href=\"https:\/\/nclinnovations.org\/covid19\/resources\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Resources &#038; Reports<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/full-width-page.php","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/pages\/83"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/comments?post=83"}],"version-history":[{"count":10,"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/pages\/83\/revisions"}],"predecessor-version":[{"id":449,"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/pages\/83\/revisions\/449"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19\/wp-json\/wp\/v2\/media?parent=83"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}